Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives

Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives

Although appreciable attempts in screening and diagnostic approaches have been achieved, prostate cancer (PCa) remains a widespread malignancy, representing the second leading cause of cancer-related death in men. Drugs currently used in PCa therapy initially show a potent anti-tumor effect, but fre...

Full description

Bibliographic Details
Main Authors: Felice Crocetto, Gianluca Russo, Erika Di Zazzo, Pasquale Pisapia, Benito Fabio Mirto, Alessandro Palmieri, Francesco Pepe, Claudio Bellevicine, Alessandro Russo, Evelina La Civita, Daniela Terracciano, Umberto Malapelle, Giancarlo Troncone, Biagio Barone
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
liquid biopsy
prostate cancer
cancer biomarkers
circulating tumor cells
extracellular vesicles
cell-free nucleic acids
Online Access:https://www.mdpi.com/2072-6694/14/13/3272

Internet

https://www.mdpi.com/2072-6694/14/13/3272

Similar Items